Epitopes recognized by CBV4 responding T cells:: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes

The present study aimed at characterizing the epitopes recognized by coxsackievirus 134 (CBV4)-specific T-cell lines established from 23 children with type 1 diabetes (T1D) and 29 healthy children with T1D risk-associated HLA genotypes. Responsiveness to VP1 region was dependent on the specific infection history as 55% of the T-cell lines from donors with neutralizing antibodies to CBV serotypes responded to VPI peptides compared to none of the T-cell lines from other donors (P = 0.01). The pattern of recognized peptides was dependent of the FILA genotype. Forty-two percent of the T-cell lines from donors carrying the HLA-(DR4)-DQB1*0302 haplotype responded to VP1 peptides 71-80 compared to none of the T-cell lines from donors without this haplotype (P = 0.02). No evidence for the existence of diabetes-specific epitopes was found. Only few epitopes were exclusive recognized by T cells from diabetic children, and in each case only one or two T-cell lines were responding. (C) 2003 Elsevier Inc. All rights reserved.